Levodopa treatment improves functional recovery after experimental stroke

Stroke

Volumn 43, Issue 2, 2012, Pages 507-513

  Ruscher, Karsten ^a   Kuric, Enida ^a   Wieloch, Tadeusz ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

dopamine and cAMP regulated neuronal phosphoprotein; dopamine receptor; levodopa; stroke recovery

Indexed keywords

BENSERAZIDE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; LEVODOPA; PHOSPHOPROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BODY WEIGHT; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; CONTROLLED STUDY; CONVALESCENCE; EXPERIMENTAL STUDY; HEMISPHERE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; SENSORIMOTOR FUNCTION; STROKE; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; ANTIPARKINSON AGENTS; ASTROCYTES; BENSERAZIDE; BLOTTING, WESTERN; CELL HYPOXIA; CELLS, CULTURED; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DRUG COMBINATIONS; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; LEVODOPA; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECOVERY OF FUNCTION; STROKE;

EID: 84856428103     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.638767     Document Type: Article

References (39)

1. Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: A prospective, randomised, double-blind study. Lancet. 2001;358: 787-790. (Pubitemid 32868727)
2. Rosser N, Heuschmann P, Wersching H, Breitenstein C, Knecht S, Floel A. Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil. 2008;89:1633-1641.
3. Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008;63:272-287. (Pubitemid 351499857)
4. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10:861-872.
5. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol. 2006;16:258-264. (Pubitemid 43949227)
6. Johansson BB, Belichenko PV. Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain. J Cereb Blood Flow Metab. 2002;22:89-96. (Pubitemid 34038387)
7. Inacio AR, Ruscher K, Wieloch T. Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke. Neurobiol Dis. 2011;41:270-278.
8. Li S, Overman JJ, Katsman D, Kozlov SV, Donnelly CJ, Twiss JL, et al. An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci. 2010;13:1496-1504.
9. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309.
10. Ruscher K, Johannesson E, Brugiere E, Erickson A, Rickhag M, Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J Cereb Blood Flow Metab. 2009;29:1796-1805.
11. Ohlsson AL, Johansson BB. Environment influences functional outcome of cerebral infarction in rats. Stroke. 1995;26:644-649.
12. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain. 2011;134:732-746.
13. Molina-Luna K, Pekanovic A, Rohrich S, Hertler B, Schubring-Giese M, Rioult-Pedotti MS, et al. Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS One. 2009;4:e7082.
14. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 2004;1029:120-123. (Pubitemid 39463314)
15. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, et al. Dopamine receptor expression on human T-and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: A flow cytometric study. J Neuroimmunol. 2002;132:34-40. (Pubitemid 35333323)
16. Ohta K, Kuno S, Mizuta I, Fujinami A, Matsui H, Ohta M. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 2003;73:617-626. (Pubitemid 36603334)
17. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: An update. Brain Behav Immun. 2010;24: 525-528.
18. Khan ZU, Koulen P, Rubinstein M, Grandy DK, Goldman-Rakic PS. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci USA. 2001;98:1964-1969. (Pubitemid 32165606)
19. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab. 2008;28:551-562. (Pubitemid 351304266)
20. Encarnacion A, Horie N, Keren-Gill H, Bliss TM, Steinberg GK, Shamloo M. Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods. 2011;196: 247-257.
21. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci. 2002;22:10291-10301. (Pubitemid 35416867)
22. Ruscher K, Erickson A, Kuric E, Inacio AR, Wieloch T. Effects of chronic Clozapine administration on apolipoprotein D levels and on functional recovery following experimental stroke. Brain Res. 2010;1321: 152-163.
23. Ouimet CC, Langley-Gullion KC, Greengard P. Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 1998;808:8-12. (Pubitemid 29003194)
24. Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P. DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci. 1984;4:111-124. (Pubitemid 14198292)
25. Luft AR, Schwarz S. Dopaminergic signals in primary motor cortex. Int J Dev Neurosci. 2009;27:415-421.
26. Lindvall O, Bjorklund A, Moore RY, Stenevi U. Mesencephalic dopamine neurons projecting to neocortex. Brain Res. 1974;81:325-331.
27. Boyson SJ, McGonigle P, Molinoff PB. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986;6:3177-3188. (Pubitemid 17186043)
28. de Almeida J, Mengod G. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment. Neuroscience. 2010;170:1133-1139.
29. Cepeda C, Colwell CS, Itri JN, Gruen E, Levine MS. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons. Eur J Neurosci. 1998;10:3491-3497. (Pubitemid 29074140)
30. Gao C, Sun X, Wolf ME. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J Neurochem. 98:1664-1677.
31. Hasbi A, O'Dowd BF, George SR. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol. 2010; 10:93-99.
32. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA. 2004;101:5117-5122. (Pubitemid 38469212)
33. Hosp JA, Pekanovic A, Rioult-Pedotti MS, Luft AR. Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning. J Neurosci. 2011;31:2481-2487.
34. Uehara T, Sumiyoshi T, Itoh H, Kurachi M. Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens. Brain Res. 2007;1133:193-199. (Pubitemid 46123247)
35. Li A, Guo H, Luo X, Sheng J, Yang S, Yin Y, et al. Apomorphineinduced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 2006;20:1263-1265.
36. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: An integrator of neurotransmission. Annu Rev Pharmacol Toxicol. 2004;44:269-296. (Pubitemid 38263842)
37. Bhat NR. Signal transduction mechanisms in glial cells. Dev Neurosci. 1995;17:267-284. (Pubitemid 26093252)
38. Ilani T, Strous RD, Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: A pathway mediated by activated T cells. FASEB J. 2004;18:1600-1602. (Pubitemid 39561646)
39. Farber K, Pannasch U, Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci. 2005;29:128-138. (Pubitemid 40613058)